|
Symbol
|
LBBRDU | DGUBKB | AEVQTQ | ADCDSQ | DJMBKB | RQORCH | DRRBKB | ADKWSQ | RMBTTV | Z0CK3Z | AEEGSQ | AHQETQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible with European Knock-In | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Sous-jacent
|
AstraZeneca Plc. / BioNTech SE / Novartis AG | Bayer AG / BioNTech SE | BioNTech SE / Pfizer Inc. / Roche PS | BioNTech SE / Merck KGaA / Pfizer Inc. | BioNTech SE / Johnson & Johnson / Pfizer Inc. | BioNTech SE / Moderna Inc. | BioNTech SE / Moderna Inc. | BioNTech SE / Moderna Inc. | BioNTech SE / Lonza Group N / Ypsomed Hldg. AG | BioNTech SE / Geberit AG / Lonza Group N | BioNTech SE / Pfizer Inc. | BioNTech SE / Johnson & Johnson / Pfizer Inc. |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
08.04.2027 | 21.05.2027 | 24.05.2027 | 15.06.2027 | 30.06.2027 | 09.11.2026 | 17.02.2027 | 24.05.2027 | 20.09.2027 | 27.05.2027 | 08.09.2027 | 10.03.2028 |
| Demande | - | 98,52 | 97,79 | 96,64 | 97,85 | - | 103,06 | 103,01 | 99,50 | - | 96,10 | 94,58 |
| Offre | - | 99,37 | 98,64 | - | 98,70 | - | - | 103,89 | 100,30 | - | 96,95 | 95,43 |